JUSTERA HEALTH LTD - SCRSF STOCK NEWS

Port North, a subsidiary of Justera Health, has expanded operations by partnering with Lune Rise Farms in South Bruce County, Ontario. The collaboration aims to enhance production of premium solventless cannabis products for recreational and therapeutic markets. Lune Rise Farms specializes in sun-grown cultivars and premium fresh frozen products, while Port North is known for its proprietary solventless extraction methods. The partnership will support the expansion of Port North's product line, which includes Hand Rolled Ice Water Hash, Strain-Specific Full-Spectrum Gummies, and Full-Spectrum Live Rosin Vapes.

Justera Health (CSE:VTAL)(OTC PINK:SCRSF) announces leadership changes as Young Cho Lee steps down as CEO effective November 15, 2024. The company's Director, Joshua Herman, has been appointed as the new Chief Executive Officer. Herman, bringing extensive public company experience, will focus on driving the company's growth and delivering value to stakeholders.

Justera Health (CSE:VTAL)(OTC PINK:SCRSF) announced the approval of 23 million restricted share units (RSUs) under its omnibus incentive plan. The RSUs, granted to employees, directors, and consultants, will vest in three stages: 50% immediately, 25% after three months, and the remaining 25% after six months from issuance. This initiative aims to retain skilled personnel and align their interests with shareholders.

Justera Health (CSE:VTAL)(OTC PINK:SCRSF) has closed a previously announced debt settlement agreement. The company settled a $355,570 debt owed to a non-arm's-length creditor by issuing 7,111,400 Units at a deemed price of C$0.05 per Unit. Each Unit comprises one Common share and one Share Purchase Warrant, exercisable at $0.05 per share for an additional Common share, valid for 5 years. The warrants include an acceleration clause for forced exercise if the company's shares trade at or above $0.10 for 5 consecutive trading days on the CSE. The issued securities will be subject to a four-month and one-day hold period from the date of issuance.

Justera Health (CSE:VTAL)(OTC PINK:SCRSF) has successfully completed the acquisition of Port North Extracts Inc., a popular cannabis brand known for its solventless extraction techniques. The transaction, closed on October 16, 2024, involved exchanging 80,000,000 Justera common shares for 100% of Port North's outstanding shares at a deemed value of $0.02 per share. Additionally, Port North warrants were exchanged for Justera warrants with an exercise price of $0.05 per share.

The acquisition aims to diversify Justera's product offerings and expand its footprint in the cannabis sector. Joshua Herman, Port North's CEO, has joined Justera's Board of Directors. Justera plans to leverage Port North's expertise and market presence to drive expansion and profitability in the coming months.

Justera Health (CSE:VTAL)(OTC PINK:SCRSF) has announced a debt settlement agreement to settle an outstanding debt of approximately C$355,570. The company will issue 7,111,400 Units at a deemed price of C$0.05 per Unit to a non-arm's-length creditor. Each Unit consists of one Common share and one Share Purchase Warrant exercisable at $0.05 per share for an additional Common share, valid for 5 years.

The warrants include an acceleration clause for forced exercise if the company's shares trade at or above $0.10 for 5 consecutive trading days. The Board believes this settlement preserves cash for ongoing operations. The transaction is subject to a 4-month and 1-day hold period from issuance. As certain directors are insiders of the creditor, this is considered a "related party transaction" under MI 61-101, but the company intends to rely on exemptions from valuation and minority shareholder approval requirements.

Justera Health (CSE:VTAL)(OTC PINK:SCRSF) has signed a definitive agreement to acquire 100% of Port North Extracts Inc., a solventless cannabis brand. The transaction involves Justera issuing 80,000,000 common shares at a deemed value of $0.02 per share to Port North shareholders. Additionally, Port North warrants will be exchanged for Justera warrants exercisable at $0.05 per share. The acquisition aligns with Justera's strategy to diversify its portfolio and expand in the health and wellness sector, particularly in the cannabis market. Joshua Herman, Port North's CEO, is expected to join Justera's Board of Directors. The deal is subject to closing conditions, including regulatory approval and Port North having a minimum cash on hand of $150,000.

Justera Health has signed a non-binding Letter of Intent (LOI) to acquire all outstanding shares of Port North Extracts, a leading solventless cannabis brand. The acquisition involves issuing 110 million Justera shares at $0.02 each, valued at $2.2 million. Port North is raising $600K through a financing initiative. The completion of the transaction depends on meeting several conditions, including regulatory approvals and Port North having $600K in cash by closing. This acquisition aims to enhance Justera's product offerings and expand its market presence.

Justera Health (OTC Pink: SCRSF) announces a delay in filing its audited annual financial statements, which may lead to a failure-to-file cease trade order by the OSC. The Company is working to finalize the filings promptly to resume normal trading conditions.